DENTSPLY SIRONA Inc. $XRAY Shares Sold by Squarepoint Ops LLC

Squarepoint Ops LLC decreased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 49.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 110,547 shares of the medical instruments supplier’s stock after selling 107,119 shares during the quarter. Squarepoint Ops LLC’s holdings in DENTSPLY SIRONA were worth $1,755,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Bank of Montreal Can increased its holdings in DENTSPLY SIRONA by 8.2% in the second quarter. Bank of Montreal Can now owns 352,524 shares of the medical instruments supplier’s stock valued at $5,598,000 after buying an additional 26,610 shares in the last quarter. AGF Management Ltd. boosted its stake in shares of DENTSPLY SIRONA by 29.6% during the 2nd quarter. AGF Management Ltd. now owns 186,424 shares of the medical instruments supplier’s stock worth $2,960,000 after acquiring an additional 42,542 shares in the last quarter. Envestnet Portfolio Solutions Inc. grew its position in shares of DENTSPLY SIRONA by 36.9% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 15,460 shares of the medical instruments supplier’s stock valued at $246,000 after acquiring an additional 4,165 shares during the period. Prudential Financial Inc. increased its stake in shares of DENTSPLY SIRONA by 67.9% in the 2nd quarter. Prudential Financial Inc. now owns 1,158,415 shares of the medical instruments supplier’s stock valued at $18,396,000 after purchasing an additional 468,415 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at about $366,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $11.14, for a total transaction of $915,708.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.50% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on XRAY. Zacks Research downgraded DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th. Barrington Research reiterated an “outperform” rating and set a $14.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday. Stifel Nicolaus set a $13.00 price target on shares of DENTSPLY SIRONA in a report on Thursday, November 6th. Mizuho set a $13.00 price objective on shares of DENTSPLY SIRONA in a research report on Friday, November 7th. Finally, UBS Group dropped their target price on shares of DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating on the stock in a research report on Tuesday, October 28th. Two investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus target price of $15.15.

DENTSPLY SIRONA Trading Down 1.3%

Shares of XRAY stock opened at $11.28 on Friday. DENTSPLY SIRONA Inc. has a fifty-two week low of $9.85 and a fifty-two week high of $20.59. The company has a debt-to-equity ratio of 1.36, a quick ratio of 0.99 and a current ratio of 1.47. The stock’s fifty day moving average is $11.67 and its two-hundred day moving average is $13.64. The firm has a market capitalization of $2.25 billion, a P/E ratio of -2.55, a PEG ratio of 0.84 and a beta of 1.01.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The business had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.33 million. DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. DENTSPLY SIRONA’s quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter last year, the company earned $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 9th. Shareholders of record on Friday, December 26th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 5.7%. The ex-dividend date of this dividend is Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -14.48%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.